IBB ETF
iShares Biotechnology ETF
IBB ETF Overview
IBB ETF (iShares Biotechnology ETF) is managed by iShares by BlackRock (US) with $10.55B in net assets. IBB expense ratio is 0.44%, holding 249 positions across sectors including Health Care, Information Technology, Financials. Inception date: 2001-02-05.
IBB performance shows a YTD return of 24.62%. The 1-year return is 46.07% and the 5-year return is 4.20%. IBB dividend yield stands at 0.16%, paid quarterly.
IBB top holdings include Gilead Sciences Inc (8.2%), Amgen Inc. (7.7%), Nvaesrtex Pharmaceuticals Inc (7.5%), Regeneron Pharmaceuticals, Inc. (5.2%), Moderna therapeutics (5.0%). Go to all IBB holdings, IBB sectors, or IBB dividends.
IBB can be compared against other funds. Use IBB overlap to find shared positions, or IBB vs another fund for a side-by-side view. IBB alternatives are available via the screener, along with tax-loss harvesting opportunities.